Recruiting
Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design
NCT07398417
- Conditions
- Fibromyalgia, Hyperalgesia, Muscular Diseases, +9 more
- Locations
-
- Clinical Research Site Glendale, Arizona, United States
- Clinical Research Site Phoenix, Arizona, United States
- Clinical Research Site Tucson, Arizona, United States
- Clinical Research Site Little Rock, Arkansas, United States